Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.4.99.6 (
sialyltransferase
)
1,546
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The CMP-sialic acids, cytidine 5'-(5-acetamido-3,5-dideoxy-beta-D-glycero-D-galacto-2-nonulopyranosy lonic acid monophosphate) (1) and cytidine 5'-(5-acetamido-9-O-acetyl-3,5-dideoxy-beta-D-glycero-D-galacto-2- nonulopyranosylonic acid monophosphate) (2) were prepared from CMP, phosphoenolpyruvate, N-acetylneuraminic acid or its 9-acetate, and a catalytic amount of ATP in the presence of immobilised pyruvate kinase, nucleoside monophosphate kinase,
inorganic pyrophosphatase
, and CMP-sialic acid synthetase. CMP-NeuAc (1) was used as a donor of N-acetylneuraminic acid in the reaction catalysed by immobilised porcine liver beta-D-Galp-(1----4)-alpha-D-GlcpNAc-(2----6)-
sialyltransferase
, alpha-D-Neup5Ac-(2----6)-beta-D-Galp-(1----4)-beta-D-GlcpNAc-(1--- -2)-alpha-D- Man-OMe (5) was obtained on a 0.1-mmol scale by enzymic sialylation of beta-D-Galp-(1----4)-beta-D-GlcpNAc-(1----2)-alpha-D-Man-OMe (4), prepared by enzymic galactosylation of beta-D-GlcpNAc-(1----2)-alpha-D-Man-OMe (3). Likewise, using 2, alpha-D-Neup-5,9Ac2-(2----6)-beta-D-Galp-(1----4)-D-GlcpNAc (7) was obtained from N-acetyl-lactosamine (6).
...
PMID:The use of immobilised glycosyltransferases in the synthesis of sialyloligosaccharides. 237 8
An Escherichia coli strain expressing three recombinant enzymes, i.e., cytidine 5'-monophosphate (CMP) kinase, sialic acid aldolase and cytidine 5'-monophosphate N-acetylneuraminic acid (CMP-NeuAc) synthetase, was utilized as a biocatalyst for the production of CMP-NeuAc. Both recombinant E. coli extract and whole cells catalyzed the production of CMP-NeuAc from CMP (20 mM), N-acetylmannosamine (40 mM), pyruvate (60 mM), ATP (1 mM), and acetylphosphate (60 mM), resulting in 90% conversion yield based on initial CMP concentration used. It was confirmed that endogenous acetate kinase can catalyze not only the ATP regeneration in the conversion of CMP to CDP but also the conversion of CDP to CTP. On the other hand, endogenous pyruvate kinase and polyphosphate kinase could not regenerate ATP efficiently. The addition of exogenous acetate kinase to the reaction mixture containing the cell extract increased the conversion rate of CMP to CMP-NeuAc by about 1.5-fold, but the addition of exogenous
inorganic pyrophosphatase
had no influence on the reaction. This E. coli strain could also be employed as an enzyme source for in situ regeneration of CMP-NeuAc in a
sialyltransferase
catalyzed reaction. About 90% conversion yield of alpha2,3-sialyl-N-acetyllactosamine was obtained from N-acetyllactosamine (20 mM), CMP (2 mM), N-acetylmannosamine (40 mM), pyruvate (60 mM), ATP (1 mM), and acetyl phosphate (80 mM) using the recombinant E. coli extract and alpha2,3-sialyltransferase.
...
PMID:Production of cytidine 5'-monophosphate N-acetylneuraminic acid using recombinant Escherichia coli as a biocatalyst. 1235 62